Drug Profile
WS 007
Alternative Names: WS007Latest Information Update: 24 Jul 2023
Price :
$50
*
At a glance
- Originator Waterstone Pharmaceuticals
- Class Antineoplastics; Antivirals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer; Hepatitis B; Hepatitis C
Most Recent Events
- 24 Jul 2023 Discontinued - Phase-I for Cancer in China (unspecified route)
- 24 Jul 2023 Discontinued - Preclinical for Hepatitis B in China (unspecified route)
- 24 Jul 2023 Discontinued - Preclinical for Hepatitis C in China (unspecified route)